FDA.reportPublic FDA data

Aptiom Titration Sample Pack

RxCUI
1491643
RxNorm name
Aptiom Titration Sample Pack
Display name
Aptiom Titration Sample Pack
Full name
Aptiom Titration Sample Pack
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AptiomESLICARBAZEPINE ACETATESumitomo Pharma America, Inc.3d0c9554-eaeb-4694-8089-00133fcadce32023-11-10Warnings, Adverse reactionsExact identifier
rxcui: 1491643

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3d0c9554-eaeb-4694-8089-00133fcadce3{7 (eslicarbazepine acetate 400 MG Oral Tablet [Aptiom]) / 7 (eslicarbazepine acetate 800 MG Oral Tablet [Aptiom]) } Pack [Aptiom Titration Sample Pack] [BPCK] · Aptiom Titration Sample Pack [PSN] · Aptiom Titration Sample Pack [SY]316These highlights do not include all the information needed to use APTIOM safely and effectively. See full prescribing information for APTIOM. APTIOM ® (eslicarbazepine acetate) tablets, for oral use Initial U.S. Approval: 201320231110